Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
Mexico

Mexico cell-based assays market highlights

  • The Mexico cell-based assays market generated a revenue of USD 273.7 million in 2023 and is expected to reach USD 430.3 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
  • In terms of segment, assay kits was the largest revenue generating products & services in 2023.
  • Assay Kits is the most lucrative products & services segment registering the fastest growth during the forecast period.

Cell-based assays market data book summary

Market revenue in 2023USD 273.7 million
Market revenue in 2030USD 430.3 million
Growth rate6.7% (CAGR from 2023 to 2030)
Largest segmentAssay kits
Fastest growing segmentAssay Kits
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationReagents, Microplates, Probes & Labels, Instruments & Software, Assay Kits, Cell Lines
Key market players worldwideBD, Bio-Rad Laboratories Inc, Corning Inc, Charles River Laboratories International Inc, Danaher Corp, Roche Holding AG, Lonza Group Ltd, Merck KGaA, Thermo Fisher Scientific Inc, Promega

Other key industry trends

  • In terms of revenue, Mexico accounted for 1.5% of the global cell-based assays market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil cell-based assays market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 901.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell-based Assays Market Companies

Name Profile # Employees HQ Website

Mexico cell-based assays market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell-based assays market will help companies and investors design strategic landscapes.


Assay kits was the largest segment with a revenue share of 43.08% in 2024. Horizon Databook has segmented the Mexico cell-based assays market based on reagents, microplates, probes & labels, instruments & software, assay kits, cell lines covering the revenue growth of each sub-segment from 2018 to 2030.


  • Mexico Cell-based Assays Products & Services Outlook (Revenue, USD Million, 2018-2030)
    • Reagents
    • Microplates
    • Probes & Labels
    • Instruments & Software
    • Assay Kits
      • Cell Growth Assays
      • Reporter Gene Assays
      • Cell Death Assays
      • Second Messenger Assays
    • Cell Lines
      • Primary Cell Lines
      • Stem Cell Lines
      • Immortalized Cell Lines
  • Mexico Cell-based Assays Application Outlook (Revenue, USD Million, 2018-2030)
    • Basic Research
    • Drug Discovery
    • Other Applications
  • Mexico Cell-based Assays End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations (CROs)

Reasons to subscribe to Mexico cell-based assays market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico cell-based assays market databook

  • Our clientele includes a mix of cell-based assays market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cell-based assays market , including forecasts for subscribers. This country databook contains high-level insights into Mexico cell-based assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico cell-based assays market

Mexico Cell-based Assays Market Outlook Share, 2024 & 2030 (US$M)

Mexico cell-based assays market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more